Detalles de la búsqueda
1.
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice.
Immunity
; 50(1): 212-224.e4, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650377
2.
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
; 388(21): 1966-1980, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37224198
3.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 385(14): 1280-1291, 2021 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587385
4.
Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study.
Gastroenterology
; 165(4): 976-985.e3, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321356
5.
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
Clin Gastroenterol Hepatol
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428709
6.
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.
Gastroenterology
; 164(2): 241-255, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36279923
7.
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 22(1): 144-153.e2, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391056
8.
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Clin Gastroenterol Hepatol
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492903
9.
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry.
Clin Gastroenterol Hepatol
; 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768673
10.
Anti-Integrin αvß6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.
Gastroenterology
; 164(4): 619-629, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634824
11.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Am J Gastroenterol
; 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38275248
12.
Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.
Dig Dis Sci
; 69(1): 45-55, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920668
13.
Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study.
Gut
; 72(4): 663-670, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623926
14.
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.
Gut
; 72(3): 443-450, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36008101
15.
Biopsy and blood-based molecular biomarker of inflammation in IBD.
Gut
; 72(7): 1271-1287, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109152
16.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644155
17.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644154
18.
Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
Gastroenterology
; 162(5): 1452-1455, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995527
19.
Early Biologic Initiation After Chronic Pouch Inflammation Diagnosis Does Not Impact Clinical Outcomes.
Clin Gastroenterol Hepatol
; 21(2): 541-542.e1, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123095
20.
Per- and Poly-Fluoroalkyl Substances Exposure is Associated With Later Occurrence Of Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38154728